An Update on Patents Covering Agents That Interfere with the Cancer Glycolytic Cascade

ChemMedChem
Serena FortunatoFilippo Minutolo

Abstract

Many tumors exhibit altered metabolic characteristics relative to normal and healthy tissues. Their metabolic profile highlights a strong prevalence of glycolysis over oxidative phosphorylation, regardless of their exposure to different oxygen levels (the Warburg effect). This condition originates from a set of gene regulations, consisting of the overexpression of some enzymes or transporters involved in the glycolytic pathway. Therefore, these effectors may constitute appealing targets for the implementation of selective therapeutic interventions against cancer. Recently, significant progress has been made in the discovery of molecules that act at various levels of the glycolytic pathway of tumor cells. So far, some of the most widely explored targets of the glycolytic cascade are represented by glucose transporters, hexokinase, 6-phosphofructokinase, enolase, pyruvate kinase, lactate dehydrogenase, and monocarboxylate transporters. The purpose of this minireview is to provide an update on some of the most recently patented bioactive molecules that are able to interfere with cancer glycolysis, and on their use in specific combination therapies.

References

May 1, 1972·The Biochemical Journal·H S Bachelard
Feb 24, 1956·Science·O WARBURG
Sep 25, 2004·Journal of Cellular Physiology·Maria L MachedaJames D Best
Nov 17, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Qi Wang, Marilyn E Morris
Feb 20, 2007·Molecular Cancer Therapeutics·Johnathan C MaherTheodore J Lampidis
Jul 29, 2008·Current Genomics·Feng-Qi Zhao, Aileen F Keating
Jan 14, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Simona Ben-Haim, Peter Ell
Jan 15, 2009·Nature Reviews. Cancer·Nicholas C Denko
Jan 22, 2010·Current Medicinal Chemistry·C GranchiF Minutolo
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anne LeChi V Dang
Mar 3, 2010·Bioorganic & Medicinal Chemistry Letters·Weihe ZhangStephen C Bergmeier
Sep 22, 2010·Protein Science : a Publication of the Protein Society·Vibhor Gupta, Rameshwar N K Bamezai
Nov 9, 2011·Disease Models & Mechanisms·Nihed Draoui, Olivier Feron
Nov 19, 2011·Cold Spring Harbor Symposia on Quantitative Biology·I MorK H Vousden
Mar 16, 2012·Journal of Medicinal Chemistry·Richard A WardKevin Hudson
Jun 12, 2012·ChemMedChem·Carlotta Granchi, Filippo Minutolo
Aug 24, 2012·Current Opinion in Oncology·Kehinde AdekolaMala Shanmugam
Dec 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark L McClelandRon Firestein
Feb 1, 2013·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Ernest K J PauwelsKalevi Kairemo
May 16, 2013·Molecular Cancer Therapeutics·Brian F ClemJason Chesney
Nov 1, 2013·Chembiochem : a European Journal of Chemical Biology·Emilia C CalvaresiPaul J Hergenrother
Nov 2, 2013·Future Medicinal Chemistry·Carlotta GranchiFilippo Minutolo
Dec 17, 2014·Pharmacology Research & Perspectives·Michel BernierIrving W Wainer
Mar 22, 2016·Oncology Letters·Gaochao DongFeng Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.